Recipients › New Jersey › Infinity Biologix LLC
Recipient organisation · UEI NPUACRBK7TV9
Infinity Biologix LLC
USAspending caveat. Figures are obligations reported by federal agencies to USAspending.gov, not payments. In USAspending's words: "An outlay occurs when federal money is actually paid out, not just promised to be paid ('obligated')." "Every agency has a Senior Accountable Official who must officially certify that the quarterly financial data submitted by their agency is accurate and complete." "If there are any discrepancies in procurement data, FPDS is the authoritative source." Contract data for the Department of Defense and the U.S. Army Corps of Engineers is published with a 90-day delay. Data loaded 30 Sep 2026. View the USAspending recipient profile.
USAspending records $34M in award obligations to Infinity Biologix LLC (Piscataway, NJ) over the fiscal years it is listed for (2023, 2024, 2025, 2026).
In FY2026, the most recent complete fiscal year, obligations were $14M, of which $14M (100%) came through contracts.
That is up 62% on FY2025 ($8.8M).
Infinity Biologix LLC ranks 268 of 712 listed organisations located in NJ by five-year obligations, and 12,756 of 30,000 nationally.
Its $1.0M-plus awards since FY2023 came from Department of Veterans Affairs and Department of Health and Human Services: 10 awards worth $39M in total award value.
Its largest contract industry is NAICS 541380 (Testing Laboratories and Services), where it ranks 15 of 81 organisations by the value of $1.0M-plus awards.
Obligations by fiscal year contracts vs assistance
| Fiscal year | All obligations | Contracts | Assistance | Change |
|---|---|---|---|---|
| FY2023 | $4,569,045 | $4,569,045 | $0 | — |
| FY2024 | $6,172,598 | $6,172,598 | $0 | +35% |
| FY2025 | $8,813,741 | $8,813,741 | $0 | +43% |
| FY2026 | $14,303,186 | $14,303,186 | $0 | +62% |
| FY2027 to date | under $1.0M | — | — | — |
A fiscal year runs 1 October to 30 September. "Contracts" are procurement award types A–D; "assistance" is everything else (grants, direct payments, loan subsidy cost, insurance, other). The contracts column is listed only where contract obligations alone reached $1.0M; the assistance figure is the remainder and may therefore include up to $1.0M of contracts.
Compared with its state and the largest recipients five listed years
| Measure | This organisation | Largest in NJ | Largest nationally |
|---|---|---|---|
| Five-year obligations (listed years) | $34M | $79B | $416B |
| FY2026 obligations | $14M | $22B | $118B |
| Contracts, five years | $34M | under $1.0M | $94B |
| Assistance, five years | $0 | $79B | $416B |
| Rank by five-year obligations | 12,756 of 30,000 | 1 of 712 in NJ | 1 |
Largest in state: Human Services, New Jersey Department of. Largest nationally: Health Care Services, California Department of. Rankings count organisations located in the state, by the sum of their listed fiscal years.
Awarding agencies $1.0M+ awards since FY2023
| # | Agency | Awards | Award value | Share |
|---|---|---|---|---|
| 1 | Department of Veterans Affairs | 7 | $30M | 77% |
| 2 | Department of Health and Human Services | 3 | $8.8M | 23% |
Contract industries NAICS
Rank within NAICS 541380: 15 of 81 organisations by $1.0M+ award value; see Testing Laboratories and Services.
Places of performance $1.0M+ awards
Counties: Middlesex County, NJ $20M · District of Columbia, DC $17M · Suffolk County, MA $1.6M
Largest awards begun since FY2023
| Awarding agency | Type | Industry or program | Award value | Begun | Place | Record |
|---|---|---|---|---|---|---|
| Department of Veterans Affairs | ContractDelivery Order | 541380 Testing Laboratories and Services | $7.8M | 29 Jun 2026 | NJ | USAspending |
| Department of Veterans Affairs | ContractDelivery Order | 541380 Testing Laboratories and Services | $6.3M | 19 Sep 2023 | DC | USAspending |
| Department of Veterans Affairs | ContractDelivery Order | 541380 Testing Laboratories and Services | $6.3M | 17 Sep 2025 | DC | USAspending |
| Department of Veterans Affairs | ContractDelivery Order | 541380 Testing Laboratories and Services | $4.4M | 5 Sep 2024 | DC | USAspending |
| Department of Health and Human ServicesNational Institutes of Health | ContractDelivery Order | 541380 Testing Laboratories and Services | $3.1M | 23 Sep 2026 | NJ | USAspending |
| Department of Health and Human ServicesNational Institutes of Health | ContractDelivery Order | 541714 Research and Development in Biotechnology (except Nanobiotechnology) | $3.0M | 11 Mar 2026 | NJ | USAspending |
| Department of Health and Human ServicesNational Institutes of Health | ContractDelivery Order | 541714 Research and Development in Biotechnology (except Nanobiotechnology) | $2.7M | 12 Mar 2025 | NJ | USAspending |
| Department of Veterans Affairs | ContractDelivery Order | 541380 Testing Laboratories and Services | $2.5M | 9 Sep 2026 | NJ | USAspending |
| Department of Veterans Affairs | ContractDelivery Order | 541380 Testing Laboratories and Services | $1.6M | 17 Sep 2024 | MA | USAspending |
| Department of Veterans Affairs | ContractDelivery Order | 541380 Testing Laboratories and Services | $1.2M | 27 Feb 2026 | NJ | USAspending |
Award value is the amount obligated to the award to date as USAspending reports it. Descriptions below are USAspending's text, unedited and truncated; those that appear to name a person are withheld.
- $7.8M, Department of Veterans Affairs, 29 Jun 2026: LONG READ SEQUENCING FOR MVP PROGRAM
- $6.3M, Department of Veterans Affairs, 19 Sep 2023: GENOMIC ANALYSIS
- $6.3M, Department of Veterans Affairs, 17 Sep 2025: GENOMIC ANALYSIS
- $4.4M, Department of Veterans Affairs, 5 Sep 2024: GENOMIC ANALYSIS
- $3.1M, Department of Health and Human Services, 23 Sep 2026: AWARD TASK ORDER FOR DNA SEQUENCING SUPPORT FOR CANCER RESEARCH NCI-GCC-DNA-061826
- $3.0M, Department of Health and Human Services, 11 Mar 2026: NIDA CENTER FOR GENETIC STUDIES. MARCH 14, 2026 - MARCH 13, 2027. N01DA-23-7787. TASK ORDER 75N95026F00001 (TO4). EO 14271: DAP-NCAP-00000089
- $2.7M, Department of Health and Human Services, 12 Mar 2025: NIDA CENTER FOR GENETIC STUDIES. MARCH 14, 2025 - MARCH 13, 2026. N01DA-23-7787. TASK ORDER 75N95025F00001 (TO3).
- $2.5M, Department of Veterans Affairs, 9 Sep 2026: LONG READ SEQUENCING FOR MVP PROGRAM
Questions and answers
How much federal money does Infinity Biologix LLC receive?
$34M in award obligations over the fiscal years it is listed for (FY2023: $4.6M; FY2024: $6.2M; FY2025: $8.8M; FY2026: $14M). Years not listed were under the $1.0M floor. Obligations are binding commitments, not payments made.
Which agencies award to Infinity Biologix LLC?
By the value of $1.0M-plus awards begun since FY2023: Department of Veterans Affairs ($30M) and Department of Health and Human Services ($8.8M).
What is the money for?
Contracts are classified under NAICS 541380 Testing Laboratories and Services and NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology).
Where is the work performed?
Primary places of performance for its larger awards: NJ ($20M), DC ($17M) and MA ($1.6M).
Is Infinity Biologix LLC a large federal recipient?
It ranks 12,756 of 30,000 organisations on this site by five-year obligations and 268 of 712 located in NJ. The site covers organisations with at least $1.0M in a fiscal year; individuals are excluded.
Where does this data come from?
USAspending.gov (U.S. Treasury), award transactions as loaded on 30 Sep 2026; fiscal-year totals via the spending-by-category endpoint and award lists via the award search endpoint. The USAspending recipient profile is the authoritative record.
Provenance
Source: USAspending.gov API v2 (U.S. Department of the Treasury, Bureau of the Fiscal Service), CC0. Fiscal-year obligations from the spending-by-category recipient ranking by recipient state (listing floor $1.0M per year); awards from the award search endpoint (new awards of $1.0M or more by base obligation date); parent and business categories from the recipient profile where fetched. Closed fiscal years are snapshots taken after year end; FY2027 is refreshed on each build. Data loaded by USAspending on 30 Sep 2026. Individuals and sole proprietors are excluded at ingest. Errors in processing are corrected at the next build; see corrections and the methodology.